Overview

Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus

Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the use of ganciclovir gel 0.3% for treatment of conjunctivitis caused by adenovirus.
Phase:
Phase 3
Details
Lead Sponsor:
Adapt Produtos Oftalmológicos Ltda.
Treatments:
Ganciclovir
Ganciclovir triphosphate
Lubricant Eye Drops